Atlas Trials

A Study of HLD-0117 in Patients With Metastatic Breast Cancer

Clinical trial NCT07524855 · RECRUITING

Trial details

NCT number
NCT07524855
Sponsor
Janssen Research & Development, LLC
Status
RECRUITING
Phase
Phase 1
Study type
INTERVENTIONAL
Metastatic Breast Cancer
Start date
2026-04-09
Primary completion
2028-04-30
Enrollment
170

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.